|
Volumn 18, Issue 5, 2001, Pages 433-438
|
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: Griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole
g
NONE
(Canada)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
FLUCONAZOLE;
GRISEOFULVIN;
ITRACONAZOLE;
TERBINAFINE;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
TINEA CAPITIS;
TREATMENT OUTCOME;
TRICHOPHYTON;
TRICHOPHYTON TONSURANS;
TRICHOPHYTON VIOLACEUM;
ADULT;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
CANADA;
FEMALE;
FLUCONAZOLE;
GRISEOFULVIN;
HUMANS;
ITRACONAZOLE;
LOGISTIC MODELS;
MALE;
NAPHTHALENES;
PROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
SOUTH AFRICA;
STATISTICS, NONPARAMETRIC;
TINEA CAPITIS;
TREATMENT OUTCOME;
TRICHOPHYTON;
|
EID: 0035173503
PISSN: 07368046
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1470.2001.01978.x Document Type: Article |
Times cited : (124)
|
References (20)
|